Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
35.45
-0.88 (-2.41%)
Aug 24, 2026, 12:35 PM EDT - Market open

Phibro Animal Health Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
95.2348.262.4232.6149.1854.39
Depreciation & Amortization
49.1644.1834.7432.5631.6630.63
Other Amortization
3.713.442.482.181.642.09
Asset Writedown & Restructuring Costs
-5.33----
Loss (Gain) From Sale of Investments
-----1.2-
Stock-Based Compensation
1.360.720.48--1.13
Other Operating Activities
16.26-0.2414.37-12.9-4.98-10.06
Change in Accounts Receivable
-17.03-55.21-8.685.34-23.63-18.21
Change in Inventory
-98.7-44.292.64-11.22-47-12.5
Change in Accounts Payable
-4.245.5612-22.8326.363.18
Change in Other Net Operating Assets
20.3432.3927.15-12.42-0.37-2.34
Operating Cash Flow
66.1380.1287.5913.3131.6548.31
Operating Cash Flow Growth
-24.23%-8.53%558.11%-57.95%-34.48%-18.61%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-53.36-38.29-41.24-51.79-37.04-29.32
Cash Acquisitions
5.35-286.53-3.28--13.51-
Investment in Securities
-12.5235-4-2327.3512
Other Investing Activities
-1.51.130.330.780.62-1.26
Investing Cash Flow
-62.04-288.69-48.19-74.02-22.58-18.58

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Short-Term Debt Issued
-7.538.596.36--
Long-Term Debt Issued
-1,182276326297617.5
Total Debt Issued
281.531,190284.59332.36297617.5
Short-Term Debt Repaid
--6.56-8.62-1.14--
Long-Term Debt Repaid
--946.01-263.3-283.32-256.38-612.13
Total Debt Repaid
-274.78-952.57-271.92-284.45-256.38-612.13
Net Debt Issued (Repaid)
6.75236.9612.6747.940.635.38
Common Dividends Paid
-19.46-19.45-19.44-19.44-19.44-19.43
Other Financing Activities
--10.38--1.47-4.84-2.94
Financing Cash Flow
-12.71207.13-6.7726.9916.34-17

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Foreign Exchange Rate Adjustments
3.19-1.14-3.30.75-1.371.14
Net Cash Flow
-5.43-2.5729.33-32.9724.0413.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
12.7741.8346.36-38.48-5.418.99
Free Cash Flow Growth
-73.97%-9.76%----24.96%
Free Cash Flow Margin
0.85%3.23%4.55%-3.94%-0.57%2.28%
Free Cash Flow Per Share
0.311.031.14-0.95-0.130.47
Levered Free Cash Flow
-17.68-86.557.79-33.570.4314.2
Unlevered Free Cash Flow
7.99-66.4771.13-22.627.7721.3

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Income Tax Paid
13.413.415.4320.4117.8519.4
Change in Working Capital
-99.59-21.5633.11-41.13-44.64-29.87
SEC Filings: 10-K · 10-Q